Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,018 public trials 2,029 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

AZD4205 in Peripheral T Cell Lymphoma Following First-Line Therapy (JACKPOT26)

NCT06511869

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Anhui Provincial Hospital (The First Affiliated Hospital of USTC) Hefei, Anhui, China
  • Peking university Third Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
View all 23 locations
View Trial Details
Completed

TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

NCT03884556

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +27 more
Locations
  • UC Irvine Cancer Center Orange, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 16 locations
View Trial Details
Completed

A Study to Assess Change in Patient Experience in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets + Intravenous Rituximab or Bruton's Tyrosine Kinase Inhibitors Tablets in the United Kingdom

NCT05555979

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Barts Health NHS Trust /ID# 252717 London, London, City of, United Kingdom
  • Norfolk and Norwich University Hospitals NHS Foundation Trust /ID# 252720 Norwich, Norfolk, United Kingdom
  • Nottingham City Hospital /ID# 252716 Nottingham, Nottinghamshire, United Kingdom
  • Oxford University Hospitals NHS Foundation Trust /ID# 252715 Oxford, Oxfordshire, United Kingdom
View Trial Details
Completed

1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation

NCT03133221

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +34 more
Locations
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details

Related conditions